Area of research
Neurology · Physiology
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Alzheimer's disease research and treatments, and Amyotrophic Lateral Sclerosis Research.
Automated Imaging Differentiation for Parkinsonism
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
Genome sequence analyses identify novel risk loci for multiple system atrophy
Brain aging rejuvenation factors in adults with genetic and sporadic neurodegenerative disease
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome
Feasibility and Proof-of-Concept of Delivering an Autonomous Music-Based Digital Walking Intervention to Persons with Parkinson’s Disease in a Naturalistic Setting
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium
Common Variants Near <scp>ZIC1</scp> and <scp>ZIC4</scp> in Autopsy‐Confirmed Multiple System Atrophy
A Modified Progressive Supranuclear Palsy Rating Scale for Virtual Assessments
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
Current Guidelines for Classifying and Diagnosing Cervical Dystonia: Empirical Evidence and Recommendations
Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium
Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases
Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
Brain volumetric deficits in <i>MAPT</i> mutation carriers: a multisite study
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat Tauopathies
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint
Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease
Telemedicine Use for Movement Disorders: A Global Survey
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Which ante mortem clinical features predict progressive supranuclear palsy pathology?